The Impact of Cognitive Impairment on Advance Care Planning and Healthcare Utilization in People With ALS
American Journal of Hospice and Palliative Medicine® · 2026
DOI: 10.1177/10499091251337464 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hospice and Palliative Medicine®, 2026. Verfasst von Mary Katherine Rohrbaugh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Jefferson Einstein Philadelphia Hospital, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Advance Care Planning, Amyotrophic Lateral Sclerosis, Cognitive Dysfunction, Patient Acceptance of Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Themen: Ethik in der Pflege
Abstract (Originalsprache)
Objective
Half of people with amyotrophic lateral sclerosis (PALS) develop cognitive impairment and/or behavioral changes, which may affect decision-making ability and participation in advance care planning (ACP) discussions. We aimed to determine the impact cognitive impairment, as measured by the Edinburgh Cognitive and Behavioural ALS Screen (ECAS), has on PALS’ ACP discussions and healthcare utilization.
Methods
PALS from a retrospective chart review were categorized into 2 groups: cognitively intact or cognitively impaired (ALS Specific Score < 77, ALS Nonspecific Score < 24, ECAS Total Score < 105, and/or ECAS Behavior or Psychosis Score 1+). Documented advance directives (AD); ACP discussions; and rates of percutaneous endoscopic gastrostomy (PEG) placement, tracheostomy placement, hospitalization within 2 weeks of death, death in hospital, and hospice utilization were recorded. Late disease stage was defined as ALS Functional Rating Scale-Revised (ALSFRS-R) score ≤ 38. Group comparisons were completed using chi-square tests, Fisher’s exact test, and independent samples t-tests with P < .05 significance.
Results
Thirty-three (47.1%) of 70 PALS met ECAS criteria for cognitive impairment. Rates of AD for PEG placement, AD for tracheostomy placement, hospitalization within 2 weeks of death, death in hospital, and hospice enrollment were not significantly different between groups ( P = .41, .62, .32, .30, .06, respectively) despite ALSFRS-R score ≥/< 38 (all P > .05).
Conclusions
ACP discussions and healthcare utilization were not affected by cognitive impairment despite disease stage. It is unknown if cognitive impairment affects healthcare decision-making processes for PALS/families. Further research examining the effect of various provider communication strategies on outcomes is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Jefferson Einstein Philadelphia Hospital, Philadelphia, PA, USA.
- ALS United Mid-Atlantic, Fort Washington, PA, USA.
- Department of Family and Community Medicine, Thomas Jeffersson University, Philadelphia, PA, USA.
- Jefferson Weinberg ALS Center, Thomas Jefferson University, Philadelphia, PA, USA.
ORCID-Profile: Gail Houseman, Amy Cunningham, Stephanie Dobak
Zitieren
APA
Rohrbaugh, M. K., Houseman, G., Cunningham, A., Dobak, S., Ilieva, H., & Kreher, M. (2026). The Impact of Cognitive Impairment on Advance Care Planning and Healthcare Utilization in People With ALS. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/10499091251337464
Vancouver
Rohrbaugh MK, Houseman G, Cunningham A, Dobak S, Ilieva H, Kreher M. The Impact of Cognitive Impairment on Advance Care Planning and Healthcare Utilization in People With ALS. American Journal of Hospice and Palliative Medicine®. 2026. doi:10.1177/10499091251337464
BibTeX
@article{Rohrbaugh2026,
author = {Rohrbaugh, Mary Katherine and Houseman, Gail and Cunningham, Amy and Dobak, Stephanie and Ilieva, Hristelina and Kreher, Margaret},
title = {The Impact of Cognitive Impairment on Advance Care Planning and Healthcare Utilization in People With ALS},
journal = {American Journal of Hospice and Palliative Medicine®},
year = {2026},
doi = {10.1177/10499091251337464}
}
EUVIMED